Events

EU Webinar: IP for Future and Emerging Technologies
APR
Tue
15
10:30 - 12:00

This was 1 month ago

Location

online

Programmes
HorizonEU L+F

Future and Emerging Technologies, (FETs) are those which are in early-stage commercialisation having recently left the lab. This webinar focusses on future and emerging technologies (FETs) and the insight that analysis of patenting activity can bring to the evolution of these technologies. Examples are chosen from EU initiatives such as Flagship projects amongst others.

Learning objectives:

  • emerging and disruptive technology definitions
  • how to identify FETs
  • basics of patent analytics
  • insights into selected FETs
  • resources for patent analytics

Registration and more information here.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.